s6y

Intellia Therapeutics, Inc.

Ticker
NTLA
CIK
1652130
Industry
In Vitro & In Vivo Diagnostic Substances

Financials 45

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. 10-Q Quarterly Report for period ending Jun 30, 2025
  7. 10-Q Quarterly Report for period ending Mar 31, 2025
  8. 10-K Annual Report for period ending Dec 31, 2024
  9. 10-Q Quarterly Report for period ending Sep 30, 2024
  10. 10-Q Quarterly Report for period ending Jun 30, 2024
Show 35 more
  1. 10-Q Quarterly Report for period ending Mar 31, 2024
  2. 10-K Annual Report for period ending Dec 31, 2023
  3. 10-Q Quarterly Report for period ending Sep 30, 2023
  4. 10-Q Quarterly Report for period ending Jun 30, 2023
  5. 10-Q Quarterly Report for period ending Mar 31, 2023
  6. 10-K Annual Report for period ending Dec 31, 2022
  7. 10-Q Quarterly Report for period ending Sep 30, 2022
  8. 10-Q Quarterly Report for period ending Jun 30, 2022
  9. 10-Q Quarterly Report for period ending Mar 31, 2022
  10. 10-K Annual Report for period ending Dec 31, 2021
  11. 10-Q Quarterly Report for period ending Sep 30, 2021
  12. 10-Q Quarterly Report for period ending Jun 30, 2021
  13. 10-Q Quarterly Report for period ending Mar 31, 2021
  14. 10-K Annual Report for period ending Dec 31, 2020
  15. 10-Q Quarterly Report for period ending Sep 30, 2020
  16. 10-Q Quarterly Report for period ending Jun 30, 2020
  17. 10-Q Quarterly Report for period ending Mar 31, 2020
  18. 10-K Annual Report for period ending Dec 31, 2019
  19. 10-Q Quarterly Report for period ending Sep 30, 2019
  20. 10-Q Quarterly Report for period ending Jun 30, 2019
  21. 10-Q Quarterly Report for period ending Mar 31, 2019
  22. 10-Q/A Quarterly Report for period ending Sep 30, 2018
  23. 10-K Annual Report for period ending Dec 31, 2018
  24. 10-Q Quarterly Report for period ending Sep 30, 2018
  25. 10-Q Quarterly Report for period ending Jun 30, 2018
  26. 10-Q Quarterly Report for period ending Mar 31, 2018
  27. 10-K/A Annual Report for period ending Dec 31, 2017
  28. 10-K Annual Report for period ending Dec 31, 2017
  29. 10-Q Quarterly Report for period ending Sep 30, 2017
  30. 10-Q Quarterly Report for period ending Jun 30, 2017
  31. 10-Q Quarterly Report for period ending Mar 31, 2017
  32. 10-K Annual Report for period ending Dec 31, 2016
  33. 10-Q Quarterly Report for period ending Sep 30, 2016
  34. 10-Q Quarterly Report for period ending Jun 30, 2016
  35. 10-Q Quarterly Report for period ending Mar 31, 2016

News 140

  1. 8-K/A Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing
Show 90 more
  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing
  11. 8-K Current report filing
  12. 8-K Current report filing
  13. 8-K Current report filing
  14. 8-K Current report filing
  15. 8-K Current report filing
  16. 8-K Current report filing
  17. 8-K Current report filing
  18. 8-K Current report filing
  19. 8-K Current report filing
  20. 8-K Current report filing
  21. 8-K Current report filing
  22. 8-K Current report filing
  23. 8-K Current report filing
  24. 8-K Current report filing
  25. 8-K Current report filing
  26. 8-K Current report filing
  27. 8-K Current report filing
  28. 8-K Current report filing
  29. 8-K Current report filing
  30. 8-K Current report filing
  31. 8-K Current report filing
  32. 8-K Current report filing
  33. 8-K Current report filing
  34. 8-K Current report filing
  35. 8-K Current report filing
  36. 8-K Current report filing
  37. 8-K Current report filing
  38. 8-K Current report filing
  39. 8-K Current report filing
  40. 8-K Current report filing
  41. 8-K Current report filing
  42. 8-K Current report filing
  43. 8-K Current report filing
  44. 8-K Current report filing
  45. 8-K Current report filing
  46. 8-K Current report filing
  47. 8-K Current report filing
  48. 8-K Current report filing
  49. 8-K Current report filing
  50. 8-K Current report filing
  51. 8-K Current report filing
  52. 8-K Current report filing
  53. 8-K Current report filing
  54. 8-K Current report filing
  55. 8-K Current report filing
  56. 8-K Current report filing
  57. 8-K Current report filing
  58. 8-K Current report filing
  59. 8-K Current report filing
  60. 8-K Current report filing
  61. 8-K Current report filing
  62. 8-K Current report filing
  63. 8-K Current report filing
  64. 8-K Current report filing
  65. 8-K Current report filing
  66. 8-K Current report filing
  67. 8-K Current report filing
  68. 8-K Current report filing
  69. 8-K Current report filing
  70. 8-K Current report filing
  71. 8-K Current report filing
  72. 8-K Current report filing
  73. 8-K Current report filing
  74. 8-K Current report filing
  75. 8-K Current report filing
  76. 8-K Current report filing
  77. 8-K Current report filing
  78. 8-K Current report filing
  79. 8-K Current report filing
  80. 8-K Current report filing
  81. 8-K Current report filing
  82. 8-K Current report filing
  83. 8-K Current report filing
  84. 8-K Current report filing
  85. 8-K Current report filing
  86. 8-K Current report filing
  87. 8-K Current report filing
  88. 8-K Current report filing
  89. 8-K Current report filing
  90. 8-K Current report filing

Showing the latest 100 of 140. Older filings are listed on EDGAR.

Ownership 413

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 3 Initial statement of beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities
Show 90 more
  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities
  11. 4 Statement of changes in beneficial ownership of securities
  12. 4 Statement of changes in beneficial ownership of securities
  13. 4 Statement of changes in beneficial ownership of securities
  14. 4 Statement of changes in beneficial ownership of securities
  15. 4 Statement of changes in beneficial ownership of securities
  16. 4 Statement of changes in beneficial ownership of securities
  17. 4 Statement of changes in beneficial ownership of securities
  18. 4 Statement of changes in beneficial ownership of securities
  19. 4 Statement of changes in beneficial ownership of securities
  20. 4 Statement of changes in beneficial ownership of securities
  21. 4 Statement of changes in beneficial ownership of securities
  22. 4 Statement of changes in beneficial ownership of securities
  23. 4 Statement of changes in beneficial ownership of securities
  24. 4 Statement of changes in beneficial ownership of securities
  25. 4 Statement of changes in beneficial ownership of securities
  26. 4 Statement of changes in beneficial ownership of securities
  27. 4 Statement of changes in beneficial ownership of securities
  28. 4 Statement of changes in beneficial ownership of securities
  29. 4 Statement of changes in beneficial ownership of securities
  30. 4 Statement of changes in beneficial ownership of securities
  31. 4 Statement of changes in beneficial ownership of securities
  32. 4 Statement of changes in beneficial ownership of securities
  33. 4 Statement of changes in beneficial ownership of securities
  34. 4 Statement of changes in beneficial ownership of securities
  35. 4 Statement of changes in beneficial ownership of securities
  36. 4 Statement of changes in beneficial ownership of securities
  37. 4 Statement of changes in beneficial ownership of securities
  38. 4 Statement of changes in beneficial ownership of securities
  39. 4 Statement of changes in beneficial ownership of securities
  40. 4 Statement of changes in beneficial ownership of securities
  41. 4 Statement of changes in beneficial ownership of securities
  42. 4 Statement of changes in beneficial ownership of securities
  43. 4 Statement of changes in beneficial ownership of securities
  44. 4 Statement of changes in beneficial ownership of securities
  45. 3 Initial statement of beneficial ownership of securities
  46. 4 Statement of changes in beneficial ownership of securities
  47. 4 Statement of changes in beneficial ownership of securities
  48. 4 Statement of changes in beneficial ownership of securities
  49. 4 Statement of changes in beneficial ownership of securities
  50. 4 Statement of changes in beneficial ownership of securities
  51. 4 Statement of changes in beneficial ownership of securities
  52. 4 Statement of changes in beneficial ownership of securities
  53. 4 Statement of changes in beneficial ownership of securities
  54. 4 Statement of changes in beneficial ownership of securities
  55. 4 Statement of changes in beneficial ownership of securities
  56. 4 Statement of changes in beneficial ownership of securities
  57. 4 Statement of changes in beneficial ownership of securities
  58. 3 Initial statement of beneficial ownership of securities
  59. 4 Statement of changes in beneficial ownership of securities
  60. 4 Statement of changes in beneficial ownership of securities
  61. 4 Statement of changes in beneficial ownership of securities
  62. 3 Initial statement of beneficial ownership of securities
  63. 4 Statement of changes in beneficial ownership of securities
  64. 4 Statement of changes in beneficial ownership of securities
  65. 4 Statement of changes in beneficial ownership of securities
  66. 4 Statement of changes in beneficial ownership of securities
  67. 4 Statement of changes in beneficial ownership of securities
  68. 4 Statement of changes in beneficial ownership of securities
  69. 4 Statement of changes in beneficial ownership of securities
  70. 3 Initial statement of beneficial ownership of securities
  71. 4 Statement of changes in beneficial ownership of securities
  72. 4 Statement of changes in beneficial ownership of securities
  73. 4 Statement of changes in beneficial ownership of securities
  74. 4 Statement of changes in beneficial ownership of securities
  75. 4 Statement of changes in beneficial ownership of securities
  76. 4 Statement of changes in beneficial ownership of securities
  77. 4 Statement of changes in beneficial ownership of securities
  78. SC 13G/A Major Shareholders
  79. SC 13G/A Major Shareholders
  80. SC 13G/A Major Shareholders
  81. 4 Statement of changes in beneficial ownership of securities
  82. SC 13G/A Major Shareholders
  83. 4 Statement of changes in beneficial ownership of securities
  84. 4 Statement of changes in beneficial ownership of securities
  85. 4 Statement of changes in beneficial ownership of securities
  86. 4 Statement of changes in beneficial ownership of securities
  87. 4 Statement of changes in beneficial ownership of securities
  88. 4 Statement of changes in beneficial ownership of securities
  89. 4 Statement of changes in beneficial ownership of securities
  90. 4 Statement of changes in beneficial ownership of securities

Showing the latest 100 of 413. Older filings are listed on EDGAR.

Prospectus 45

  1. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  2. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  3. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  4. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  5. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  6. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  7. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  8. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  9. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  10. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Show 35 more
  1. S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
  2. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  3. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  4. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  5. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  6. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  7. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  8. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  9. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  10. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  11. S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
  12. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  13. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  14. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  15. S-3/A Registration statement for specified transactions by certain issuers
  16. S-3 Registration statement for specified transactions by certain issuers
  17. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  18. S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
  19. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  20. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  21. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  22. S-3 Registration statement for specified transactions by certain issuers
  23. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  24. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  25. S-1MEF A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
  26. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  27. S-1/A General form of registration statement for all companies including face-amount certificate companies
  28. S-1/A General form of registration statement for all companies including face-amount certificate companies
  29. S-1/A General form of registration statement for all companies including face-amount certificate companies
  30. S-1/A General form of registration statement for all companies including face-amount certificate companies
  31. S-1 General form of registration statement for all companies including face-amount certificate companies
  32. DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  33. DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  34. DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  35. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Proxies 20

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  4. DEF 14A Definitive proxy statements
  5. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  6. DEF 14A Definitive proxy statements
  7. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  8. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  9. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  10. DEF 14A Definitive proxy statements
Show 10 more
  1. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  2. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  3. DEF 14A Definitive proxy statements
  4. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  5. DEF 14A Definitive proxy statements
  6. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  7. DEF 14A Definitive proxy statements
  8. DEF 14A Definitive proxy statements
  9. DEF 14A Definitive proxy statements
  10. DEF 14A Definitive proxy statements

Other 63

  1. SCHEDULE 13G
  2. 144 Filing for proposed sale of securities under Rule 144
  3. 144 Filing for proposed sale of securities under Rule 144
  4. 144 Filing for proposed sale of securities under Rule 144
  5. SCHEDULE 13G
  6. 144 Filing for proposed sale of securities under Rule 144
  7. SCHEDULE 13G
  8. ARS Annual report to security holders
  9. SCHEDULE 13G
  10. SCHEDULE 13G/A
Show 53 more
  1. SCHEDULE 13G/A
  2. SCHEDULE 13G/A
  3. SCHEDULE 13G
  4. SCHEDULE 13G/A
  5. SCHEDULE 13G/A
  6. 144 Filing for proposed sale of securities under Rule 144
  7. SCHEDULE 13G
  8. SCHEDULE 13G
  9. SCHEDULE 13G/A
  10. SCHEDULE 13G
  11. ARS Annual report to security holders
  12. SCHEDULE 13G/A
  13. SCHEDULE 13G/A
  14. ARS Annual report to security holders
  15. 144 Filing for proposed sale of securities under Rule 144
  16. 144 Filing for proposed sale of securities under Rule 144
  17. 144 Filing for proposed sale of securities under Rule 144
  18. 144 Filing for proposed sale of securities under Rule 144
  19. 144 Filing for proposed sale of securities under Rule 144
  20. ARS Annual report to security holders
  21. CT ORDER Order Granting Confidential Treatment
  22. EFFECT Notice of Effectiveness
  23. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  24. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  25. UPLOAD Letter (PDF)
  26. EFFECT Notice of Effectiveness
  27. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  28. CT ORDER Order Granting Confidential Treatment
  29. CT ORDER Order Granting Confidential Treatment
  30. UPLOAD Letter (PDF)
  31. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  32. POSASR Post-effective Amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR
  33. EFFECT Notice of Effectiveness
  34. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  35. UPLOAD Letter (PDF)
  36. CT ORDER Order Granting Confidential Treatment
  37. CT ORDER Order Granting Confidential Treatment
  38. CT ORDER Order Granting Confidential Treatment
  39. CERTNAS
  40. EFFECT Notice of Effectiveness
  41. 8-A12B Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
  42. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  43. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  44. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  45. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  46. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  47. UPLOAD Letter (PDF)
  48. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  49. UPLOAD Letter (PDF)
  50. UPLOAD Letter (PDF)
  51. UPLOAD Letter (PDF)
  52. UPLOAD Letter (PDF)
  53. D Exempt (Private) Offering